A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia

S Piemontese, F Ciceri, M Labopin, A Bacigalupo… - Leukemia, 2015 - nature.com
The use of unmanipulated graft is increasingly adopted in the setting of allogeneic
hematopoietic stem cell transplantation from haploidentical family donors (haplo-SCT) in …

Allogeneic marrow stem-cell transplantation from human leukocyte antigen–identical siblings versus human leukocyte antigen–allelic–matched unrelated donors (10 …

I Yakoub-Agha, F Mesnil, M Kuentz… - Journal of clinical …, 2006 - ascopubs.org
Purpose To investigate the influence of donor type (human leukocyte antigen [HLA]-identical
sibling donor versus HLA-A–, HLA-B–, HLA-Cw–, HLA-DRB1–, and HLA-DQB1–identical …

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the …

N Santoro, A Ruggeri, M Labopin, A Bacigalupo… - Journal of hematology & …, 2017 - Springer
Background Allogenic hematopoietic stem cell transplantation (allo-SCT) is the most
effective post-remission treatment for adults with high-risk acute lymphoblastic leukemia …

Hematopoietic stem cell transplantation for acute myeloid leukemia

A Takami - International journal of hematology, 2018 - Springer
Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) yields a high rate
of curability for acute myeloid leukemia (AML), it is also associated with transplant-related …

Effect of postremission chemotherapy before human leukocyte antigen–identical sibling transplantation for acute myelogenous leukemia in first complete remission

MS Tallman, PA Rowlings, G Milone… - Blood, The Journal …, 2000 - ashpublications.org
Allogeneic bone marrow transplantation is an effective postremission strategy for patients
with acute myelogenous leukemia (AML) in first complete remission (CR). The value of …

Haploidentical versus matched-sibling transplant in adults with Philadelphia-negative high-risk acute lymphoblastic leukemia: a biologically phase III randomized …

YU Wang, QF Liu, LP Xu, KY Liu, XH Zhang, X Ma… - Clinical Cancer …, 2016 - AACR
Purpose: Although matched-sibling donor (MSD) hematopoietic stem-cell transplantation
(HSCT) has an established role in the management of adults with acute lymphoblastic …

Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell …

J Sierra, B Storer, JA Hansen, JW Bjerke… - Blood, The Journal …, 1997 - ashpublications.org
Transplantation of hematopoietic stem cells from an HLA-compatible unrelated volunteer is
an option for patients with acute leukemia lacking a family match. However, criteria for …

[HTML][HTML] Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the …

CJ Lee, BN Savani, M Mohty, M Labopin… - …, 2017 - ncbi.nlm.nih.gov
Allogeneic blood or marrow hematopoietic cell transplantation continues to be the most
potent anti-leukemic treatment for adult patients with standard, high-risk, or chemo-refractory …

[HTML][HTML] Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation

XJ Huang, DH Liu, KY Liu, LP Xu, H Chen… - Biology of blood and …, 2009 - Elsevier
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains one of the best
therapeutic options to cure acute leukemia (AL). However, many patients have no human …

Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy …

N Basara, A Schulze, U Wedding, M Mohren… - Leukemia, 2009 - nature.com
Between 1996 and 2004, a total of 708 patients were enrolled in the acute myeloid
leukaemia (AML)'96 and '02 studies of the East German Study Group (OSHO). Of these, 138 …